Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fuller

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
International Journal of Particle Therapy|February 25, 2026
Defining a Quantitative Threshold for Adaptive Re-planning using a Percentile-based Scoring SystemAlexandra O Leone, Christine B Peterson, Anna Lee, et al.
The Laryngoscope|July 22, 2016
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinomaRyan P Goepfert, Jan S Lewin, Martha P Barrow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2024
A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapyCoen Hurkmans, Jean-Emmanuel Bibault, Kristy K Brock, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2026
Global dose prescription variances exemplified through oropharynx cancer: when is 70 Gray 70 Gray?Christian Rønn Hansen, Tony Tadic, Manju Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Advances in Radiation Oncology|October 21, 2020
Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose CoverageMona Kamal, Abdallah S R Mohamed, Clifton David Fuller, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal CancerKatherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Advances in Radiation Oncology|December 11, 2020
A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer: IMRT, IMPT, and Tongue-Deviating Oral StentsStephen R Grant, Tyler D Williamson, Sonja Stieb, et al.
JCO Clinical Cancer Informatics|May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
International Journal of Particle Therapy|February 25, 2026
Defining a Quantitative Threshold for Adaptive Re-planning using a Percentile-based Scoring SystemAlexandra O Leone, Christine B Peterson, Anna Lee, et al.
The Laryngoscope|July 22, 2016
Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinomaRyan P Goepfert, Jan S Lewin, Martha P Barrow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2024
A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapyCoen Hurkmans, Jean-Emmanuel Bibault, Kristy K Brock, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2026
Global dose prescription variances exemplified through oropharynx cancer: when is 70 Gray 70 Gray?Christian Rønn Hansen, Tony Tadic, Manju Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Advances in Radiation Oncology|October 21, 2020
Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose CoverageMona Kamal, Abdallah S R Mohamed, Clifton David Fuller, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal CancerKatherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Advances in Radiation Oncology|December 11, 2020
A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer: IMRT, IMPT, and Tongue-Deviating Oral StentsStephen R Grant, Tyler D Williamson, Sonja Stieb, et al.
JCO Clinical Cancer Informatics|May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
Pageof 20